Treatment/Assay | AO/EB (%) | DCF (%) |
---|---|---|
Untreated | < 1 ± 0 | 2 ± 1 |
VC (10 mM) | 26 ± 2 | 28 ± 2 |
VK3 (10 μM) | 35 ± 3 | 39 ± 3 |
VK3 (10 μM) + VC (10 mM) | 48 ± 3 | 55 ± 3 |
CP55,940 (10 nM) | < 1 ± 0 | 1 ± 1 |
CP55,940 (10 nM) + VC (10 mM) | 1 ± 1b | 1 ± 1b |
CP55,940 (10 nM) + VK3 (10 μM) | 2 ± 1a | 8 ± 2a |
CP55,940 (10 nM) + VC (10 mM) + VK3 (10 μM) | 3 ± 1c | 14 ± 2c |
NAC (1 mM) | < 1 ± 0 | 1 ± 0 |
NAC (1 mM) + VC (10 mM) | 2 ± 1b | 7 ± 2b |
NAC (1 mM) + VK3 (10 μM) | 4 ± 1a | 12 ± 2a |
NAC (1 mM) + VC (10 mM) + VK3 (10 μM) | 7 ± 1c | 20 ± 2c |